Hölsken A - Search Results

1

DNA methylation-based classification of central nervous system tumours.

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Rei… See abstract for full author list ➔ Capper D, et al. Among authors: holsken a. Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14. Nature. 2018. PMID: 29539639 Free PMC article.

2

Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases.

Hölsken A, Eyüpoglu IY, Lueders M, Tränkle C, Dieckmann D, Buslei R, Hahnen E, Blümcke I, Siebzehnrübl FA. Hölsken A, et al. Acta Neuropathol. 2006 Aug;112(2):205-15. doi: 10.1007/s00401-006-0082-8. Epub 2006 Jun 14. Acta Neuropathol. 2006. PMID: 16773328

3

Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas.

Buslei R, Hölsken A, Hofmann B, Kreutzer J, Siebzehnrubl F, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I. Buslei R, et al. Among authors: holsken a. Acta Neuropathol. 2007 May;113(5):585-90. doi: 10.1007/s00401-006-0184-3. Epub 2007 Jan 13. Acta Neuropathol. 2007. PMID: 17221204

4

The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.

Coras R, Hölsken A, Seufert S, Hauke J, Eyüpoglu IY, Reichel M, Tränkle C, Siebzehnrübl FA, Buslei R, Blümcke I, Hahnen E. Coras R, et al. Among authors: holsken a. Mol Cancer Ther. 2007 Jun;6(6):1745-54. doi: 10.1158/1535-7163.MCT-06-0763. Epub 2007 May 31. Mol Cancer Ther. 2007. PMID: 17541035

5

Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.

Hölsken A, Kreutzer J, Hofmann BM, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R. Hölsken A, et al. Brain Pathol. 2009 Jul;19(3):357-64. doi: 10.1111/j.1750-3639.2008.00180.x. Epub 2008 May 29. Brain Pathol. 2009. PMID: 18540944 Free PMC article.

6

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.

Burghaus S, Hölsken A, Buchfelder M, Fahlbusch R, Riederer BM, Hans V, Blümcke I, Buslei R. Burghaus S, et al. Among authors: holsken a. Virchows Arch. 2010 Mar;456(3):287-300. doi: 10.1007/s00428-009-0873-0. Virchows Arch. 2010. PMID: 20069432

7

Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.

Hölsken A, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R. Hölsken A, et al. Acta Neuropathol. 2010 May;119(5):631-9. doi: 10.1007/s00401-010-0642-9. Epub 2010 Feb 4. Acta Neuropathol. 2010. PMID: 20131060

8

EGFR signaling regulates tumor cell migration in craniopharyngiomas.

Hölsken A, Gebhardt M, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R. Hölsken A, et al. Clin Cancer Res. 2011 Jul 1;17(13):4367-77. doi: 10.1158/1078-0432.CCR-10-2811. Epub 2011 May 11. Clin Cancer Res. 2011. PMID: 21562037

9

Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.

Stache C, Hölsken A, Fahlbusch R, Flitsch J, Schlaffer SM, Buchfelder M, Buslei R. Stache C, et al. Among authors: holsken a. Neuro Oncol. 2014 Jan;16(2):256-64. doi: 10.1093/neuonc/not195. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24305709 Free PMC article.

10

Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

Hölsken A, Stache C, Schlaffer SM, Flitsch J, Fahlbusch R, Buchfelder M, Buslei R. Hölsken A, et al. Pituitary. 2014 Dec;17(6):546-56. doi: 10.1007/s11102-013-0543-8. Pituitary. 2014. PMID: 24356780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters